A. Baruchel

H. Dombret, A. Baruchel, M. Robin, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.

C. Pui, R. Pieters, A. Baruchel, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern

R. Pieters, A. Baruchel, S. Meshinchi, 2013, Leukemia.

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia

R. Pieters, A. Baruchel, D. Reinhardt, 2011, Haematologica.

hydrocarbons; a case-control study exposure to potential sources of benzene and other Acute childhood leukaemia and environmental

A. Baruchel, K. Kébaili, J. Clavel, 2004 .

Acute Leukaemia Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality

H. Dombret, A. Baruchel, M. Robin, 2003 .

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.

A. Baruchel, M. Schrappe, A. Biondi, 2020, Haematologica.

Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.

A. Fischer, G. Raymond, A. Baruchel, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population

P. Auquier, A. Baruchel, G. Leverger, 2018, Haematologica.

Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

M. Loh, A. Baruchel, H. Cavé, 2015, Haematologica.

Chronic myelomonocytic leukemia: from biology to therapy.

A. Baruchel, E. Wattel, P. Fenaux, 1997, Hematology and cell therapy.

Case Report: Hyperammonemic Encephalopathy Linked to Ureaplasma spp. and/or Mycoplasma hominis Systemic Infection in Patients Treated for Leukemia, an Emergency Not to Be Missed

A. Baruchel, A. Birgy, N. Boissel, 2022, Frontiers in Oncology.

Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia

P. Auquier, A. Baruchel, G. Leverger, 2021, HemaSphere.

Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia

J. Soulier, E. Clappier, A. Baruchel, 2016, Oncotarget.

Childhood ALL: ContRoL it or not?

A. Baruchel, 2011, Blood.

Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single‐strand conformation polymorphism studies and highly resolutive PCR derived methods: implication for a general strategy of minimal residual disease detection

F. Sigaux, J. Cayuela, A. Baruchel, 1995, British journal of haematology.

Unique BHLHB3 overexpression in pediatric acute myeloid leukemia with t(6;11)(q27;q23)

R. Stam, R. Pieters, A. Baruchel, 2014, Leukemia.

The ontogeny of P-glycoprotein in the developing human blood–brain barrier: implication for opioid toxicity in neonates

A. Baruchel, G. Leverger, M. Schrappe, 2015, Pediatric Research.

Contribution of HLA-A/B/C/DRB1/DQB1 common haplotypes to donor search outcome in unrelated hematopoietic stem cell transplantation.

A. Baruchel, G. Leverger, K. Yakouben, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit – multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group

A. Baruchel, G. Leverger, T. Leblanc, 2005, Leukemia.

Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality

H. Dombret, A. Baruchel, M. Robin, 2003, Bone Marrow Transplantation.

Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

A. Baruchel, G. Leverger, T. Leblanc, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Population Pharmacokinetics and Dosing Optimization of Vancomycin in Children with Malignant Hematological Disease

A. Baruchel, F. Duquesne, M. Fakhoury, 2014, Antimicrobial Agents and Chemotherapy.

Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation.

A. Baruchel, D. Bensoussan, K. Yakouben, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Lymphoid Variant of Hypereosinophilic Syndrome

G. Salles, A. Baruchel, M. Copin, 2014, Medicine.

Laboratory parameters in prognostic sickle cell disease cohort studies in children: a systematic review and lessons for an appropriate strategy for analysis

A. Baruchel, D. Mohamed, C. Alberti, 2019 .

The use of ICU resources in CAR-T cell recipients: a hospital-wide study

A. Baruchel, J. Larghero, É. Azoulay, 2022, Annals of Intensive Care.

Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.

A. Baruchel, E. Macintyre, Y. Bertrand, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Persistent osteoarticular pain in children: early clinical and laboratory findings suggestive of acute lymphoblastic leukemia (a multicenter case-control study of 147 patients)

A. Baruchel, B. Bader-Meunier, M. Lorrot, 2020, Pediatric rheumatology online journal.

Prolonged agammaglobulinemia despite unaltered B-cell lymphopoiesis after peritransplant-rituximab administration in a child.

A. Baruchel, K. Yakouben, J. Dalle, 2008, Transplantation.

New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children

A. Fischer, A. Baruchel, G. Leverger, 2011, Haematologica.

Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children

A. Baruchel, G. Leverger, T. Leblanc, 2007, Leukemia.

Dasatinib (SPRYCEL®) in Children and Adolescents with Relapsed or Refractory Leukemia: Preliminary Results of the CA180018 Phase I/II Study from the ITCC Consortium.

R. Pieters, A. Baruchel, M. L. Boer, 2007 .

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.

S. Rives, A. Baruchel, I. Baumann, 2021, Blood advances.

Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment

A. Baruchel, A. Abarrategi, H. Cavé, 2019, Leukemia.

Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia

A. Baruchel, H. Cavé, C. Preudhomme, 2010, British journal of haematology.

Monosomy-7 in childhood hemopoietic disorders.

A. Baruchel, G. Leverger, R. Berger, 1990, Leukemia.

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)

E. Clappier, H. Dombret, A. Baruchel, 2021, Biomedicines.

Managing children with chronic myeloid leukaemia (CML)

A. Baruchel, A. Biondi, F. Millot, 2014, British journal of haematology.

Granulocyte C olony-Stimulati ng F actor i n I nduction Treatment o f C hildren W ith N on-Hodgkin's L ymphoma: A R andomized S tudy o f t he F rench S ociety o f Pediatric O ncology

A. Baruchel, D. Frappaz, C. Patte, 2002 .

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.

A. Baruchel, C. Preudhomme, H. Sobol, 2009, Blood.

Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02

A. Baruchel, G. Leverger, P. Rohrlich, 2017, Journal of pediatric hematology/oncology.

High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23).

M. D. Den Boer, R. Pieters, A. Baruchel, 2011, Blood.

High IGSF 4 expression in pediatric M 5 acute myeloid leukemia with t ( 9 ; 11 ) ( p 22 ; q 23 ) *

R. Pieters, A. Baruchel, M. L. Boer, 2010 .

Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study.

J. Cayuela, A. Baruchel, Y. Bertrand, 2014, Blood.

TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.

F. Sigaux, J. Cayuela, A. Baruchel, 1996, Blood.

BCOR and BCORL1 mutations in pediatric acute myeloid leukemia

M. Fornerod, R. Pieters, A. Baruchel, 2013, Haematologica.

Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia

R. Pieters, A. Baruchel, S. Kajigaya, 2012, Leukemia.

When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).

H. Dombret, A. Baruchel, S. Chevret, 2009, Leukemia research.

Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia

T. Molina, A. Baruchel, E. Macintyre, 2022, Modern Pathology.

CBL mutations do not frequently occur in paediatric acute myeloid leukaemia

R. Stam, R. Pieters, A. Baruchel, 2012, British journal of haematology.

e- Blood Myelodysplasia and leukemia of Fanconi anemia are associated with a speciﬁc pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

F. Sigaux, J. Soulier, A. Baruchel, 2011 .

Different Prevalence of Drug Metabolism Gene Polymorphisms (GSTP and GSTT) in FA Patients Compared to a Normal Population.

R. Porcher, J. Soulier, A. Baruchel, 2005 .

Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study

A. Baruchel, Y. Bertrand, N. Rama, 2022, Journal of Cancer.

Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22‐positive B‐cell acute lymphoblastic leukaemia

A. Baruchel, N. Boissel, B. Bruno, 2020, British journal of haematology.

Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup

J. Soulier, A. Baruchel, V. Najfeld, 2003, Leukemia.

Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium.

M. Loh, C. Pui, S. Rives, 2021, Blood.

The International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped-Study): Objectives and Preliminary Results

A. Baruchel, Chi-kong Li, A. Biondi, 2012 .

Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents

A. Baruchel, T. Leblanc, Chi-kong Li, 2017, Cancer.

Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia

A. Baruchel, C. Mullighan, M. Konopleva, 2021, Haematologica.

Efficacy of Tyrosine Kinase Inhibitors in Ph-like Acute Lymphoblastic Leukemia harboring ABL-class Rearrangements.

J. Soulier, E. Clappier, H. Dombret, 2019, Blood.

Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.

H. Dombret, A. Baruchel, C. Gisselbrecht, 1992, Bone marrow transplantation.

Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia.

A. Baruchel, G. Leverger, J. Reiffers, 1992, Blood.

Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study.

C. Pui, R. Pieters, A. Baruchel, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study.

S. Rives, A. Baruchel, A. Attarbaschi, 2022, The Lancet. Haematology.

All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia.

A. Baruchel, P. Rohrlich, C. Chomienne, 2001, The hematology journal : the official journal of the European Haematology Association.

Impact of glucose‐6‐phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study

A. Baruchel, J. Elion, C. Alberti, 2013, British journal of haematology.

Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia

A. Baruchel, B. Bader-Meunier, I. Zaccaria, 2009, Haematologica.

Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia

J. Soulier, E. Clappier, A. Baruchel, 2013, Haematologica.

Thyroid hormone and folinic acid in young children with Down syndrome: the phase 3 ACTHYF trial

A. Baruchel, M. Polak, D. Borderie, 2019, Genetics in Medicine.

Excellent prognosis of late relapses of ETV 6 / RUNX 1-positive childhood acute lymphoblastic leukemia : lessons from the FRALLE 93 protocol Running title : Prognosis of ETV 6 / RUNX 1 leukemia relapses

J. Cayuela, A. Baruchel, G. Leverger, 2018 .

Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol

J. Cayuela, A. Baruchel, G. Leverger, 2012, Haematologica.

Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations

J. Soulier, E. Clappier, A. Baruchel, 2011, Leukemia.

Mapping epigenetic regulator gene mutations in cytogenetically normal pediatric acute myeloid leukemia

R. Pieters, A. Baruchel, D. Reinhardt, 2014, Haematologica.

Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemia

H. Dombret, A. Baruchel, F. Lacombe, 2019, Leukemia.

Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia

H. Dombret, A. Baruchel, F. Lacombe, 2018, Hematological oncology.

Risk factors for pneumonia in immunocompromised patients with influenza.

A. Baruchel, É. Azoulay, M. Darmon, 2010, Respiratory medicine.

Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia

A. Baruchel, A. Attarbaschi, D. Ziegler, 2022, Pediatric blood & cancer.

Cranial polyneuropathy as the first manifestation of a severe COVID‐19 in a child

A. Baruchel, D. Germanaud, Y. Bouchoucha, 2020, Pediatric blood & cancer.

Leukaemic transformation in a 10‐year‐old girl with SRP54 congenital neutropenia

A. Baruchel, T. Leblanc, C. Bellanné-Chantelot, 2022, British journal of haematology.

IKZF1 alterations predict poor prognosis in adult and pediatric T-ALL.

J. Cayuela, H. Dombret, A. Baruchel, 2020, Blood.

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group

A. Baruchel, G. Leverger, M. Labopin, 2018, HemaSphere.

Myeloid leukaemia in children with down syndrome: Report of the registry‐based French experience between 1990 and 2003

A. Baruchel, J. Clavel, Y. Pérel, 2010, Pediatric blood & cancer.

Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

A. Baruchel, M. Hermiston, B. K. Masouleh, 2022, Haematologica.

Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real‐world setting: Results from the NEUF study

A. Baruchel, N. Boissel, A. Maschan, 2022, Pediatric blood & cancer.

Impact of therapy in a cohort of unselected children with Down Syndrome‐associated Acute Lymphoblastic Leukaemia

A. Baruchel, Y. Bertrand, P. Lutz, 2016, British journal of haematology.

The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults

A. Baruchel, M. Robin, T. Leblanc, 2018, British journal of haematology.

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.

R. Pieters, A. Baruchel, D. Reinhardt, 2009, Blood.

Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients

A. Baruchel, M. de Tersant, L. Goldwirt, 2022, Pharmaceuticals.

Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

A. Baruchel, P. Chevallier, I. Yakoub-Agha, 2022, Journal of Cancer Research and Clinical Oncology.

No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia.

R. Pieters, A. Baruchel, D. Reinhardt, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia

A. Baruchel, H. Cavé, T. Blauwblomme, 2013, Leukemia.

In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.

A. Fischer, A. Baruchel, E. Haddad, 1997, Leukemia & lymphoma.

Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study

P. Auquier, A. Baruchel, G. Leverger, 2016, Bone Marrow Transplantation.

Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE Study

D. Hémon, A. Baruchel, C. Bergeron, 2014, Cancer Causes & Control.

Ovarian reserve after treatment with alkylating agents during childhood.

A. Baruchel, F. de Vathaire, A. Millischer, 2015, Human reproduction.

Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study

P. Auquier, A. Baruchel, G. Leverger, 2021, Bone Marrow Transplantation.

Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study

J. Cayuela, A. Baruchel, G. Leverger, 2009, BMC Cancer.

Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia

K. Davis, S. Rives, A. Baruchel, 2018, Blood.

Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.

A. Baruchel, G. Socié, P. Ribaud, 1995, Bone marrow transplantation.

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

A. Baruchel, G. Leverger, T. Leblanc, 2001, Cancer Chemotherapy and Pharmacology.

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

H. Dombret, A. Baruchel, G. Leverger, 2006, Leukemia.

Economic Evaluation of Recombinant Human Granulocyte Colony-Stimulating Factor in Very High-Risk Childhood Acute Lymphoblastic Leukemia

A. Baruchel, G. Leverger, T. Leblanc, 2003, Journal of pediatric hematology/oncology.

Molecular analysis of clonality in Castleman's disease.

J. Soulier, A. Baruchel, É. Oksenhendler, 1995, Blood.

Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/KMT2A Rearrangements in a Modern Therapy Era: A Retrospective International Study

M. Loh, C. Pui, A. Baruchel, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breakpoint-specific multiplex PCR allows the detection of IKZF 1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia

J. Soulier, E. Clappier, A. Baruchel, 2012 .

Use of immunophenotype as part of the prognostic stratification for childhood ALL in the FRALLE 93 protocol.

A. Baruchel, G. Leverger, G. Schaison, 1994, Leukemia & lymphoma.

Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center

A. Baruchel, S. Sarnacki, B. Neven, 2019, Acta obstetricia et gynecologica Scandinavica.

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l'Enfant et de L'Adolescent Study.

P. Auquier, A. Baruchel, G. Leverger, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells.

H. Dombret, A. Baruchel, C. Gardin, 2020, Leukemia research.

The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia

Stanley W. K. Ng, J. Dick, A. Baruchel, 2018, Leukemia.

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies

A. Baruchel, M. Labopin, M. Robin, 2007, Bone Marrow Transplantation.

Fungal contamination of water and water-related surfaces in three hospital wards with immunocompromised patients at risk for invasive fungal infections

H. Dombret, A. Baruchel, F. Derouin, 2010 .

Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey

A. Fischer, C. Bodemer, J. Casanova, 2012, Medicine.

COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)

A. Baruchel, G. Leverger, P. Rohrlich, 2021, Bulletin du Cancer.

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

C. Pui, W. Kamps, A. Baruchel, 2002, The Lancet.

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.

C. Pui, W. Kamps, A. Baruchel, 2000, The New England journal of medicine.

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)

A. Baruchel, H. Tilly, D. Blaise, 2000, Bone Marrow Transplantation.

The interplay between anticancer challenges and the microbial communities from the gut

O. Tenaillon, A. Baruchel, A. Birgy, 2022, European Journal of Clinical Microbiology & Infectious Diseases.

Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.

S. Raimondi, C. Pui, R. Pieters, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network

A. Baruchel, C. Picard, H. Cavé, 2015, Nature Genetics.

Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.

Chloé Talarmin, Steven Kerob, François Cartier, 2020, Cytotherapy.

Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+ Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Waseem Qasim, Nicolas Boissel, Sylvain Fouliard, 2018, Blood.

Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?

A. Baruchel, Y. Bertrand, I. van der Sluis, 2022, British journal of haematology.

Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation

A. Baruchel, L. Silverman, J. Whitlock, 2016, Haematologica.

L‐asparaginase treatment in acute lymphoblastic leukemia

C. Pui, R. Pieters, A. Baruchel, 2011, Cancer.

Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.

K. Davis, S. Rives, A. Baruchel, 2019, The Lancet. Oncology.

Neonatal cancer.

A. Baruchel, H. Brisse, D. Orbach, 2013, The Lancet. Oncology.

The spectrum of mutations, including four novel ones, in the thiamine‐responsive megaloblastic anemia gene SLC19A2 of eight families

J. Cayuela, A. Baruchel, H. Mandel, 2000, Human mutation.

Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

Rob Pieters, Brian V. Balgobind, Jan Trka, 2011, Haematologica.

Maintenance Therapy With Interleukin-2 for Childhood AML

A. Baruchel, G. Leverger, A. Rousseau, 2018, HemaSphere.

Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment.

A. Baruchel, S. Chevret, J. Dalle, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam

O. Tenaillon, A. Baruchel, A. Birgy, 2020, Scientific Reports.

Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

R. Pieters, A. Baruchel, D. Reinhardt, 2012, Pediatric blood & cancer.

A landscape of germ line mutations in a cohort of inherited bone marrow failure patients.

J. Soulier, E. Clappier, A. Baruchel, 2018, Blood.

Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome

F. Sigaux, J. Cayuela, A. Baruchel, 2008, Haematologica.

Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.

A. Baruchel, G. Leverger, É. Lepage, 1992, Leukemia.

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

R. Pieters, A. Baruchel, M. Schrappe, 2018, The Lancet. Haematology.

An effective modestly intensive re‐induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia

J. Berkhof, A. Baruchel, P. Rohrlich, 2018, British journal of haematology.

Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.

M. D. Den Boer, R. Pieters, A. Baruchel, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia

A. Baruchel, G. Leverger, T. Leblanc, 2006, BMC Cancer.

NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity.

H. Dombret, A. Baruchel, P. Romeo, 2009, Blood.

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia

R. Pieters, J. Cayuela, A. Baruchel, 2011, Haematologica.

Increasing completion of asparaginase treatment in childhood acute lymphoblastic leukaemia (ALL): summary of an expert panel discussion

A. Baruchel, K. Schmiegelow, I. van der Sluis, 2020, ESMO Open.

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

C. Pui, A. Baruchel, L. Silverman, 2012, The New England journal of medicine.

Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.

R. Porcher, J. Cayuela, A. Baruchel, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE)

A. Baruchel, G. Leverger, C. Hill, 2000, British Journal of Cancer.

Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.

A. Baruchel, G. Leverger, T. Leblanc, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables

A. Baruchel, G. Leverger, T. Leblanc, 1998, British journal of haematology.

NKX 3 . 1 is a direct TAL 1 target gene that mediates proliferation of TAL 1-expressing human T cell acute lymphoblastic leukemia

J. Cayuela, A. Baruchel, P. Romeo, 2010 .

No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities

S. Raimondi, C. Pui, R. Pieters, 2005, Leukemia.

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

C. Pui, N. Heerema, A. Baruchel, 2003, Leukemia.

Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.

A. Baruchel, C. Deswarte, S. Spicuglia, 2017, Blood advances.

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins

J. Cayuela, H. Dombret, A. Baruchel, 2022, Blood Cancer Journal.

The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.

B. Nadel, O. Delattre, F. Sigaux, 2007, Blood.

Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE)

D. Hémon, A. Baruchel, G. Leverger, 2012, Cancer Causes & Control.

A phase II trial of partially incompatible bone marrow transplantation for high‐risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti‐LFA‐1 and anti‐CD2 antibodies

A. Baruchel, M. Cavazzana‐Calvo, B. Lacour, 1996 .

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.

J. Cayuela, H. Dombret, A. Baruchel, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NUP98/JARID1A Is a New Recurrent Genetic Abnormality in Pediatric Acute Megakaryoblastic Leukemia with a Distinct HOX -Gene Expression Pattern

R. Pieters, A. Baruchel, S. Meshinchi, 2012 .

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

R. Pieters, A. Baruchel, J. V. van Galen, 2011, Blood.

The clinical and biological characteristics of NUP98-KDM5A pediatric acute myeloid leukemia

R. Stam, A. Baruchel, R. Ries, 2020, Haematologica.

BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells

H. Dombret, A. Baruchel, P. Hérait, 2015, Oncotarget.

miR-9 is a tumor suppressor in pediatric AML with t(8;21)

R. Pieters, M. Fornerod, M. D. Den Boer, 2014, Leukemia.

Juvenile myelomonocytic leukaemia and Noonan syndrome

Corinne Alberti, Alain Verloes, Christine Chomienne, 2014, Journal of Medical Genetics.

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia

A. Baruchel, H. Cavé, N. Philip, 2010, Journal of Medical Genetics.

Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia

A. Baruchel, G. Leverger, E. Macintyre, 2018, Leukemia.

MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML

M. Fornerod, R. Pieters, A. Baruchel, 2018, Oncogene.

miR-139-5p controls translation in myeloid leukemia through EIF4G2

M. Fornerod, A. Baruchel, S. Emmrich, 2016, Oncogene.

Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.

A. Baruchel, G. Leverger, S. Chevret, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia

Rob Pieters, Martin Zimmermann, Askar Obulkasim, 2015, Haematologica.

Bromodomain and extraterminal protein inhibitors in pediatrics: A review of the literature

A. Baruchel, J. Schulte, F. Doz, 2017, Pediatric blood & cancer.

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.

J. Soulier, J. Cayuela, A. Baruchel, 2018, Blood.

MLL Rearrangements Impact Outcome in HOXA-deregulated T-lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Michael C. Rusch, M. Loh, N. Heerema, 2016, Leukemia.

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse

F. Sigaux, J. Soulier, E. Clappier, 2011 .

Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity

I. Bernstein, H. Dombret, A. Baruchel, 2010, Leukemia.

Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias

F. Sigaux, J. Soulier, E. Clappier, 2006, Leukemia.

translocation defining a new T-ALL subtype in very young children genomic duplications in human T-cell acute leukemia (T-ALL), the The C-MYB locus is involved in chromosomal translocation and

J. Soulier, J. Cayuela, H. Dombret, 2013 .

Day-care, early common infections and childhood acute leukaemia: a multicentre French case–control study

D. Hémon, A. Baruchel, G. Leverger, 2002, British Journal of Cancer.

SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) Recommendations for the Management of Tumor Lysis Syndrome (TLS) With Rasburicase: An Observational Survey

A. Baruchel, G. Leverger, C. Patte, 2008, Journal of pediatric hematology/oncology.

Risk assessment and medical decision model for prophylaxis and treatment of hyperuricemia and tumor lysis syndrome (TLS): International expert panel analysis

C. Pui, B. Coiffier, B. Cheson, 2007 .

Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.

A. Baruchel, M. Arcangeli, B. Colsch, 2017, Blood advances.

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.

J. Downing, M. Relling, C. Pui, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ARID5B, IKZF1 and Non-Genetic Factors in the Etiology of Childhood Acute Lymphoblastic Leukemia: The ESCALE Study

D. Hémon, A. Baruchel, A. Bonaventure, 2015, PloS one.

The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, May 6-7, 2009

C. Pui, A. Baruchel, M. Schrappe, 2009, Leukemia.

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.

E. Gilson, F. Sigaux, J. Soulier, 2023, Cell stem cell.

Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.

Jérôme Larghero, Christine Chomienne, Valérie Vanneaux, 2010, Stem cells and development.

Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

M. Fischer, A. Baruchel, D. Frappaz, 2019, Pediatric blood & cancer.

Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know?

A. Baruchel, D. Mohamed, C. Alberti, 2021, Children.

Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?

S. Rives, A. Baruchel, I. Caruana, 2022, Frontiers in Pediatrics.

Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia

E. Clappier, A. Baruchel, H. Cavé, 2021, Leukemia.

Road Traffic and Childhood Leukemia: The ESCALE Study (SFCE)

D. Hémon, A. Baruchel, G. Leverger, 2010, Environmental health perspectives.

Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE)

D Hémon, D. Hémon, A. Baruchel, 2009, Occupational and Environmental Medicine.

Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE)

D. Hémon, A. Baruchel, G. Leverger, 2007, Environmental health perspectives.

Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study

A. Baruchel, M. Elmaleh, D. Mohamed, 2016, British journal of haematology.

Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).

A. Baruchel, G. Leverger, T. Leblanc, 1996, Bone marrow transplantation.

Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity

A. Baruchel, G. Leverger, O. Fenneteau, 2021, Cancers.

Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL)

E. Clappier, J. Cayuela, H. Dombret, 2022, Journal of clinical medicine.

Ponatinib in childhood Philadelphia chromosome-positive leukaemias: an international registry of childhood chronic myeloid leukaemia study.

A. Baruchel, Y. Bertrand, F. Millot, 2020, European journal of cancer.

From class waivers to precision medicine in paediatric oncology.

David T. W. Jones, S. Pfister, A. Baruchel, 2017, The Lancet. Oncology.

Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.

H. Dombret, A. Baruchel, G. Leverger, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PF270 IS ACUTE MYELOBLASTIC LEUKEMIA IN CHILDREN UNDER TWO YEARS OF AGE A SPECIFIC ENTITY? A REPORT FROM THE FRENCH ELAM02 STUDY GROUP

A. Baruchel, G. Leverger, T. Leblanc, 2019, HemaSphere.

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group

A. Baruchel, G. Leverger, T. Leblanc, 2019, HemaSphere.

BIOV-111 a European Phase II Trial of Clofarabine (Evoltra®) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia.

A. Baruchel, P. Kearns, S. Joel, 2006 .

[Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP].

A. Baruchel, F. Bruneel, B. Bader-Meunier, 2000, Annales de medecine interne.

Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience

A. Baruchel, G. Leverger, P. Rohrlich, 2017, Bone Marrow Transplantation.

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia

M. Fornerod, R. Pieters, A. Baruchel, 2016, Oncotarget.

High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome

M. D. Boer, R. Pieters, A. Baruchel, 2010, Leukemia.

Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.

R. Pieters, A. Baruchel, D. Reinhardt, 2010, European journal of cancer.

Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis

A. Baruchel, V. Baud, F. Pflumio, 2014, Leukemia.

Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort).

P. Auquier, A. Baruchel, G. Leverger, 2015, International journal of epidemiology.

High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.

A. Baruchel, V. V. D. van der Velden, D. Reinhardt, 2012, Blood.

A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee)

A. Baruchel, G. Leverger, H. Cavé, 2016, Pediatric blood & cancer.

French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia

A. Baruchel, S. Chevret, P. Rohrlich, 2012, Experimental Hematology & Oncology.

Amendment history : Corrigendum ( March 2017 ) Biallelic inactivation of REV 7 is associated with Fanconi anemia

J. Soulier, A. Baruchel, D. Bluteau, 2019 .

Diagnosis of Fanconi anemia in patients with bone marrow failure

J. Soulier, A. Baruchel, D. Stoppa-Lyonnet, 2009, Haematologica.

Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation.

A. Fischer, A. Baruchel, M. Cavazzana‐Calvo, 1994, Bone Marrow Transplantation.

aplastic anemia antithymocyte globulin with prednisone for treatment of severe Multicenter randomized study comparing cyclosporine-A alone and

A. Baruchel, G. Leverger, J. Reiffers, 2013 .

INVESTIGATION OF PHAGOCYTE OXIDATIVE METABOLISM IN MICROAMOUNTS OF WHOLE BLOOD FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

M. Dougados, A. Baruchel, R. Golub, 1984 .

Bone markers after total body irradiation in childhood

A. Baruchel, J. Souberbielle, H. Esperou, 2010, Bone Marrow Transplantation.

Outcome of children treated with haematopoietic‐stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene

A. Baruchel, D. Auboeuf, J. Dalle, 2011, British journal of haematology.

First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.

A. Baruchel, G. Leverger, Y. Bertrand, 2008, European journal of cancer.

Comparison Between Allogeneic and Autologous Bone Marrow Transplantation for Childhood Acute Lymphoblastic Leukemia in Second Remission

A. Baruchel, G. Leverger, J. Stéphan, 1996 .

Liposomal daunorubicin (Daunoxome) and polyethylated glycol conjugated asparaginase (PEG-ASPA) in children with relapsed and refractory acute lymphoblastic leukemia treated on compassionate basis.

A. Baruchel, G. Leverger, J. Vannier, 2008, Journal of the Egyptian National Cancer Institute.

Syndromes of inappropriate macrophage activation in childhood.

A. Baruchel, G. Schaison, 1990, Nouvelle revue francaise d'hematologie.

Relationship between cytomegalovirus (CMV) reactivation, CMV‐driven immunity, overall immune recovery and graft‐versus‐leukaemia effect in children

R. Porcher, A. Baruchel, K. Yakouben, 2014, British journal of haematology.

Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).

A. Baruchel, G. Leverger, G. Dini, 2005, Blood.

Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.

F. Sigaux, J. Soulier, E. Clappier, 2018, Cancer discovery.

Successful Treatment of Bacteremia Due to NDM-1-Producing Morganella morganii with Aztreonam and Ceftazidime-Avibactam Combination in a Pediatric Patient with Hematologic Malignancy

O. Tenaillon, A. Baruchel, H. Jacquier, 2018, Antimicrobial Agents and Chemotherapy.

Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop.

A. Baruchel, M. Arcangeli, I. Naguibneva, 2021, Blood advances.

Molecular response in two children with relapsed acute myeloid leukemia treated with a combination of gemtuzumab ozogamicin and cytarabine.

J. Cayuela, A. Baruchel, G. Leverger, 2006, Haematologica.

Maintenance therapy in childhood acute myeloid leukemia.

A. Baruchel, G. Leverger, T. Leblanc, 2004, Annals of hematology.

Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias

Rob Pieters, R. Pieters, A. Baruchel, 2015, International Journal of Hematology.

Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE Study (SFCE)

D. Hémon, D. Zélénika, A. Baruchel, 2011, Cancer Causes & Control.

Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE).

D. Hémon, A. Baruchel, G. Leverger, 2007, International journal of epidemiology.

HLA alleles and haplotypes in French North African immigrants.

A. Baruchel, G. Leverger, K. Yakouben, 2006, Human immunology.

Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy, and childhood acute leukemia: the ESTELLE study

D. Hémon, A. Baruchel, G. Leverger, 2015, Cancer Causes & Control.

Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms

D. Hémon, D. Zélénika, A. Baruchel, 2013, Cancer Causes & Control.

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A french multicenter study

Vahid Asnafi, Richard Garand, Mikael Roussel, 2014, Cytometry. Part B, Clinical cytometry.

The majority of myeloid‐antigen‐positive (My+) childhood B‐cell precursor acute lymphoblastic leukaemias express TEL‐AML1 fusion transcripts

F. Sigaux, A. Baruchel, E. Macintyre, 1997, British journal of haematology.

Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapy

A. Baruchel, O. Hermine, V. Asnafi, 2006, Leukemia.

Genetic polymorphisms of Th2 interleukins, history of asthma or eczema and childhood acute lymphoid leukaemia: Findings from the ESCALE study (SFCE).

D. Hémon, A. Baruchel, G. Leverger, 2018, Cancer epidemiology.

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression

A. Baruchel, J. Gross, C. Deswarte, 2014, EMBO molecular medicine.

The clinical relevance of BAALC and ERG expression levels in pediatric AML

R. Pieters, A. Baruchel, D. Reinhardt, 2013, Leukemia.

An interstitial 11q23 deletion proven to be a rearrangement interrupting the MLL gene in an infant with acute myeloblastic leukemia.

A. Baruchel, R. Berger, T. Leblanc, 1996, Leukemia.

Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.

J. Cayuela, H. Dombret, A. Baruchel, 2019, Blood advances.

[Imerslund's disease. Clinical and biological aspects. Apropos of 6 cases].

A. Baruchel, P. Schneider, J. Vannier, 1997, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY

S. Rives, A. Baruchel, S. Grupp, 2022, HemaSphere.

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.

Marc C. Jacob, H. Dombret, A. Baruchel, 2014, Cytometry. Part B, Clinical cytometry.

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

K. Davis, S. Rives, A. Baruchel, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation

A. Baruchel, K. Yakouben, J. Dalle, 2010, Bone Marrow Transplantation.

Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL

J. Cayuela, H. Dombret, A. Baruchel, 2021, Journal of Hematology & Oncology.

Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols

A. Baruchel, E. Macintyre, S. Chevret, 2021, Leukemia.

H. Dombret, A. Baruchel, M. Tesio, 2017, Leukemia.

Acute Myeloid Leukemia (AML) in Children: Results of the French Trials

A. Baruchel, G. Leverger, T. Leblanc, 2001 .

Incidence and Prognosis of RTKs and RAS Mutations in CBF AML. A Retrospective Study of French Adult ALFA and Pediatric LAME Trials.

H. Dombret, A. Baruchel, T. Leblanc, 2004 .

GENOMIC AND DRUG RESPONSE PROFILING OF FATAL TCF3-HLF-POSITIVE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIES RECURRENT MUTATION PATTERNS AND NOVEL THERAPEUTIC OPTIONS

J. Korbel, H. Lehrach, P. Rosenstiel, 2015 .

Addition of Liposomal Daunorubicin (DaunoXome®) to FLAG Significantly Improves Treatment Response in Pediatric Relapsed AML: Final Results From the International Randomised Phase III Study Relapsed AML 2001/01.

A. Baruchel, S. Ha, D. Reinhardt, 2009 .

A. Baruchel, P. Chevallier, I. Yakoub-Agha, 2021, Journal of Cancer Research and Clinical Oncology.

Wilms’ Tumor 1 Gene Mutations in Childhood Acute Myeloid Leukemia: A New Prognostic factor with Implications for MRD Detection

R. Pieters, A. Baruchel, D. Reinhardt, 2008 .

Generic formulations of imatinib for treatment of Philadelphia chromosome–positive leukemia in pediatric patients

A. Baruchel, M. Schrappe, H. Shimada, 2018, Pediatric blood & cancer.

Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology.

A. Baruchel, D. Frappaz, C. Patte, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990–1999

D. Hémon, A. Baruchel, G. Leverger, 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[Prognosis of acute lymphoblastic leukemia in children. Results of the French protocol FRALLE 93].

A. Baruchel, G. Leverger, G. Schaison, 2001, Bulletin de l'Academie nationale de medecine.

Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.

H. Dombret, A. Baruchel, L. Adès, 2014, European journal of cancer.

Phase II study of dasatinib in children and adolescents with newly diagnosed chronic phase chronic myelogenous leukemia (CP-CML) or Philadelphia-positive (Ph+) leukemias resistant or intolerant to imatinib.

A. Baruchel, P. Kearns, T. Barrett, 2010 .

The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study): Pronostic Consideration

A. Baruchel, Chi-kong Li, A. Biondi, 2014 .

Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

S. Rives, Krysta D Schlis, A. Baruchel, 2016 .

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia

A. Baruchel, H. Cavé, É. Lainey, 2021, Frontiers in Oncology.

Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.

A. Baruchel, C. Gisselbrecht, M. Boiron, 1991, Nouvelle revue francaise d'hematologie.

Ovarian function and spontaneous pregnancy after hematopoietic stem cell transplantation for leukemia before puberty An L.E.A. cohort study.

P. Auquier, A. Baruchel, G. Leverger, 2023, Transplantation and cellular therapy.

Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).

A. Baruchel, G. Leverger, T. Leblanc, 1996, Hematology and cell therapy.

Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood

A. Fischer, A. Baruchel, H. Esperou, 2011, BMC pediatrics.

Final height and gonad function after total body irradiation during childhood

A. Baruchel, H. Esperou, J. Michon, 2006, Bone Marrow Transplantation.

POPULATION PHARMACOKINETICS AND DOSING OPTIMIZATION OF TEICOPLANIN IN CHILDREN WITH MALIGNANT HAEMATOLOGICAL DISEASE

A. Baruchel, X. Declèves, É. Jacqz-Aigrain, 2015, Archives of Disease in Childhood.

Brothers and sisters of childhood acute leukemia survivors: Their long‐term quality of life and its determinants

P. Auquier, A. Baruchel, Y. Bertrand, 2022, Cancer medicine.

Erratum to: Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms

D. Hémon, D. Zélénika, A. Baruchel, 2014, Cancer Causes and Control.

The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children

A. Baruchel, C. Zwaan, A. Balduzzi, 2023, Journal of clinical medicine.

Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE)

D. Hémon, A. Baruchel, Y. Bertrand, 2015, British Journal of Cancer.

Family cancer history and risk of childhood acute leukemia (France)

D. Hémon, A. Baruchel, G. Leverger, 2001, Cancer Causes & Control.

Acute childhood leukaemia and environmental exposure to potential sources of benzene and other hydrocarbons; a case-control study

D. Hémon, A. Baruchel, G. Leverger, 2004, Occupational and Environmental Medicine.

Bridging to CAR-T Cells in Children, Adolescents, and Young Adults with ALL

A. Baruchel, 2022, The EBMT/EHA CAR-T Cell Handbook.

Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL

C. Plass, H. Dombret, A. Baruchel, 2023, Molecular Cancer.

Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents

A. Baruchel, Chi-kong Li, B. De Moerloose, 2017, Haematologica.

Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium

R. Pieters, A. Baruchel, M. L. Boer, 2010 .

B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL

E. Clappier, A. Baruchel, A. Attarbaschi, 2019, Front. Oncol..

Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trial

A. Baruchel, G. Leverger, C. Preudhomme, 2017, Pediatric hematology and oncology.

Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia

A. Baruchel, G. Leverger, C. Oudot, 2010, Archives of Disease in Childhood.

Symptomatic osteonecrosis in French survivors of childhood and adolescent leukemia: a clinical and MRI study of LEA cohort

P. Auquier, A. Baruchel, C. Berger, 2023, Pediatric hematology and oncology.

Head and neck presentations of B‐NHL and B‐AL in children/adolescents: Experience of the LMB89 study

A. Baruchel, G. Leverger, C. Patte, 2014, Pediatric blood & cancer.

Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE)

D. Hémon, A. Baruchel, G. Leverger, 2012, Cancer Causes & Control.

Prognostic Factors and Treatment in Pediatric Acute Myeloblastic Leukemia: French Trials

A. Baruchel, G. Leverger, T. Leblanc, 1997 .

Family history of autoimmune thyroid disease and childhood acute leukemia.

D. Hémon, A. Baruchel, G. Leverger, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Considerations for tisagenlecleucel dosing rationale.

S. Rives, A. Baruchel, U. Jäger, 2018 .

[Management of CAR-T cell-related encephalopathy syndrome in adult and pediatric patients: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

A. Baruchel, I. Yakoub-Agha, A. Moreau, 2019, Bulletin du cancer.

Treatment of Childhood T Cell Lymphoblastic Lymphoma (TLL), Results of the SFOP LMT96.

A. Baruchel, G. Leverger, C. Patte, 2005 .

Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group

A. Baruchel, G. Leverger, C. Preudhomme, 2023, Leukemia.

A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

A. Baruchel, B. Forget, S. Ballas, 1992, The Journal of clinical investigation.

Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial

K. Davis, S. Rives, A. Baruchel, 2019, Biology of Blood and Marrow Transplantation.

Mixed Lineage Leukemia Rearrangements (MLL-R) Are Determinants of High Risk Disease in Homeobox A (HOXA)-deregulated T-Lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

M. Loh, N. Heerema, J. Soulier, 2015 .

[Eligibility of patients for CAR T-cell: Expert opinion-based collaborative work by the SFGM-TC].

A. Baruchel, I. Yakoub-Agha, J. Bay, 2021, Bulletin du cancer.

Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE Study (SFCE)

D. Hémon, D. Zélénika, A. Baruchel, 2012, Cancer Causes & Control.

MATERNAL COFFEE AND ALCOHOL CONSUMPTION DURING PREGNANCY, PARENTAL SMOKING AND RISK OF CHILDHOOH ACUTE LEUKEMIA Short title: Maternal coffee and alcohol consumption, parental smoking and childhood leukemia

D. Hémon, A. Baruchel, G. Leverger, 2010 .

Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.

A. Baruchel, X. Declèves, É. Jacqz-Aigrain, 2015, British journal of clinical pharmacology.

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

A. Baruchel, J. Beijnen, C. Zwaan, 2019, Clinical Pharmacokinetics.

Erratum to: Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms

D. Hémon, D. Zélénika, A. Baruchel, 2013, Cancer Causes & Control.

Down syndrome and leukemia: from basic mechanisms to clinical advances

A. Baruchel, A. Lane, J. Klusmann, 2023, Haematologica.

Imatinib Is Efficient but Has a Negative Impact On Growth in Children with Previously Untreated chronic Myelogenous Leukaemia (CML) in Early Chronic Phase (CP): Results of the French National Phase IV Trial.

J. Cayuela, A. Baruchel, T. Leblanc, 2009 .

Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia (ISAKIDS): Interim Analysis

A. Baruchel, G. Leverger, K. Yoo, 2021, Blood.

Broad-Range PCR-Electrospray Ionization Mass Spectrometry for Detection and Typing of Adenovirus and Other Opportunistic Viruses in Stem Cell Transplant Patients

A. Baruchel, G. Socié, J. Dalle, 2013, Journal of Clinical Microbiology.

childhood acute leukaemia Household exposure to pesticides and risk of

D. Hémon, A. Baruchel, G. Leverger, 2006 .

Cellular and humoral immunity elicited by influenza vaccines in pediatric hematopoietic-stem cell transplantation.

A. Baruchel, M. Frémond, K. Yakouben, 2012, Human immunology.

Advanced Phases at Diagnosis of Childhood Chronic Myeloid Leukemia : The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study)

A. Baruchel, Chi-kong Li, A. Biondi, 2017 .

A European Phase II Study (BIOV-111) of Clofarabine (Evoltra®) in Refractory and Relapsed Childhood Acute Lymphoblastic Leukemia: Final Results.

A. Baruchel, P. Kearns, S. Joel, 2007 .

Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL

A. Baruchel, E. Macintyre, V. Asnafi, 2023, HemaSphere.

Detection of minimal residual disease in leukemias: a critical approach.

A. Baruchel, G. Schaison, 1990, Nouvelle revue francaise d'hematologie.

A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia.

A. Baruchel, G. Leverger, J. Reiffers, 1992, Journal of Autoimmunity.

Genetic diversity of the human adenovirus species C DNA polymerase

A. Baruchel, B. Klonjkowski, J. Dalle, 2018, Antiviral research.

Clinical activity of ERY001 (erythrocyte encapsulated l-asparaginase) and native l-asparaginase (L-ASP) in combination with COOPRALL regimen in phase III randomized trial in patients with relapsed acute lymphoblastic leukemia (ALL).

A. Baruchel, J. Stéphan, X. Thomas, 2015 .

Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia

R. Pieters, A. Baruchel, S. Kajigaya, 2013, British journal of haematology.

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse

F. Sigaux, J. Soulier, E. Clappier, 2011, The Journal of Experimental Medicine.

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse

F. Sigaux, J. Soulier, E. Clappier, 2011, Journal of Experimental Medicine.

J. Cayuela, A. Baruchel, G. Leverger, 2009, BMC Cancer.

Translocation t(11;11)(q13;q23) and HRX gene rearrangement associated with therapy-related leukemia in a child previously treated with VP16.

A. Baruchel, R. Berger, T. Leblanc, 1994, Leukemia.

Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study.

A. Baruchel, D. Teachey, N. Shukla, 2022, Journal of Clinical Oncology.

P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY

A. Baruchel, D. Teachey, A. Vora, 2022, HemaSphere.

EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.

M. Loh, B. Burkhardt, A. Baruchel, 2022, Blood.

Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data

A. Baruchel, S. Chevret, N. Boissel, 2023, HemaSphere.

University of Groningen Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia Hollink,

R. Pieters, A. Baruchel, D. Reinhardt, 2011 .

Preclinical Study Of The Bromodomain Inhibitor OTX015 In Acute Myeloid (AML) and Lymphoid (ALL) Leukemias

H. Dombret, A. Baruchel, P. Hérait, 2013 .

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse

F. Sigaux, J. Soulier, E. Clappier, 2011, The Journal of experimental medicine.

In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure.

A. Baruchel, G. Leverger, T. Leblanc, 2020, Blood advances.

Upfront azacitidine (AZA) in juvenile myelomonocytic leukemia (JMML): Interim analysis of the prospective AZA-JMML-001 study.

S. Rives, A. Baruchel, I. Baumann, 2019, Journal of Clinical Oncology.

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

P. Vyas, N. Potter, A. Baruchel, 2019, Blood.

Infant T‐cell acute lymphoblastic leukaemia with t(6;7) (TCRB‐MYB) translocation

A. Baruchel, J. Meijerink, A. Vora, 2021, British journal of haematology.

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia

R. Pieters, A. Baruchel, D. Reinhardt, 2011, Haematologica.

Cyclin D2 Dysregulation by Chromosomal Translocations to TCR Loci in T-Cell Acute Lymphoblastic Leukemia (T-ALL).

F. Sigaux, J. Soulier, E. Clappier, 2006 .

Impact of age , leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era : results of the FRALLE 93 study

J. Cayuela, A. Baruchel, G. Leverger, 2015 .

PS962 PHASE 1 RESULTS OF ZUMA-4: KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

A. Baruchel, M. Hermiston, R. Jain, 2019, HemaSphere.

Identification of Gene Expression Signatures Accurately Predicting Cytogenetic Subtypes in Pediatric Acute Myeloid Leukemia.

R. Pieters, J. Cayuela, A. Baruchel, 2008 .

Dexamethasone(DEX)(6mg/sm/d) and Prednisolone(PRED)(60mg/sm/d) in Induction Therapy of Childhood ALL Are Equally Effective: Results of the 2nd Interim Analysis of EORTC Trial 58951

A. Baruchel, P. Rohrlich, Y. Bertrand, 2008 .

Dasatinib in Children and Adolescents with Relapsed or Refractory Leukemia: Interim Results of the CA180-018 Phase I Study from the ITCC Consortium.

R. Pieters, A. Baruchel, M. L. Boer, 2008 .

Relapse as acute monoblastic leukemia (AML-M5) of t(6;9) acute myeloblastic leukemia (AML-M2).

A. Baruchel, R. Berger, P. Jonveaux, 1992, Leukemia.

[Role of allogeneic hematopoietic cell transplantation after anti-CD19 CAR T-cell treatment: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

A. Baruchel, I. Yakoub-Agha, K. Yakouben, 2022, Bulletin du cancer.

L‐asparaginase treatment in acute lymphoblastic leukemia

C. Pui, R. Pieters, A. Baruchel, 2011, Cancer.

S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDY

B. Burkhardt, A. Baruchel, M. Hermiston, 2022, HemaSphere.

Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience

E. Clappier, A. Baruchel, H. Cavé, 2019, Blood.

[Management of CAR-T cell-related encephalopathy syndrome in adult and pediatric patients: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

A. Baruchel, I. Yakoub-Agha, A. Moreau, 2020, Bulletin du cancer.

P. Auquier, A. Baruchel, G. Leverger, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Juvenile myelomonocytic leukaemia and Noonan syndrome

A. Baruchel, H. Cavé, S. Gazal, 2014, Journal of Medical Genetics.

Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation.

A. Baruchel, D. Bensoussan, K. Yakouben, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hypermethylation of the calcitonin gene and leukemia.

F. Sigaux, A. Baruchel, 1991, Nouvelle revue francaise d'hematologie.

Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.

R. Pieters, A. Baruchel, D. Reinhardt, 2010, European journal of cancer.

The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.

B. Nadel, O. Delattre, F. Sigaux, 2007, Blood.

Impact of childhood leukemia on siblings: their long-term perception of family functioning and its relationship with their psychosocial characteristics using structural equation modeling

P. Auquier, A. Baruchel, Y. Bertrand, 2023, Journal of cancer survivorship : research and practice.

Impact of age , leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era : results of the FRALLE 93 study

J. Cayuela, A. Baruchel, G. Leverger, 2009 .

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse

F. Sigaux, E. Clappier, A. Baruchel, 2011 .

Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam

O. Tenaillon, A. Baruchel, A. Birgy, 2020, Scientific Reports.

COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)

A. Baruchel, G. Leverger, P. Rohrlich, 2020, Bulletin du Cancer.